These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 34932218)
21. Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells. Zhu H; Yang X; Liu J; Zhou L; Zhang C; Xu L; Qin Q; Zhan L; Lu J; Cheng H; Sun X Cell Stress Chaperones; 2015 Mar; 20(2):217-20. PubMed ID: 25248493 [TBL] [Abstract][Full Text] [Related]
22. [Eukaryotic elongation factor 2 kinase and cancer]. Wang GZ; Qi X; Li J Yao Xue Xue Bao; 2015 Jul; 50(7):808-13. PubMed ID: 26552140 [TBL] [Abstract][Full Text] [Related]
23. Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia. Moore CE; Mikolajek H; Regufe da Mota S; Wang X; Kenney JW; Werner JM; Proud CG Mol Cell Biol; 2015 May; 35(10):1788-804. PubMed ID: 25755286 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression. De Gassart A; Demaria O; Panes R; Zaffalon L; Ryazanov AG; Gilliet M; Martinon F EMBO Rep; 2016 Oct; 17(10):1471-1484. PubMed ID: 27572820 [TBL] [Abstract][Full Text] [Related]
27. Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity. Jan A; Jansonius B; Delaidelli A; Bhanshali F; An YA; Ferreira N; Smits LM; Negri GL; Schwamborn JC; Jensen PH; Mackenzie IR; Taubert S; Sorensen PH Acta Neuropathol Commun; 2018 Jul; 6(1):54. PubMed ID: 29961428 [TBL] [Abstract][Full Text] [Related]
28. Electroacupuncture Improves Synaptic Function in SAMP8 Mice Probably via Inhibition of the AMPK/eEF2K/eEF2 Signaling Pathway. Dong W; Yang W; Li F; Guo W; Qian C; Wang F; Li C; Lin L; Lin R Evid Based Complement Alternat Med; 2019; 2019():8260815. PubMed ID: 31641367 [TBL] [Abstract][Full Text] [Related]
29. Amyloid beta induces Fmr1-dependent translational suppression and hyposynchrony of neural activity via phosphorylation of eIF2α and eEF2. Lizarazo S; Yook Y; Tsai NP J Cell Physiol; 2022 Jul; 237(7):2929-2942. PubMed ID: 35434801 [TBL] [Abstract][Full Text] [Related]
30. Bicuculline regulated protein synthesis is dependent on Homer1 and promotes its interaction with eEF2K through mTORC1-dependent phosphorylation. Gladulich LFH; Xie J; Jensen KB; Kamei M; Paes-de-Carvalho R; Cossenza M; Proud CG J Neurochem; 2021 May; 157(4):1086-1101. PubMed ID: 32892352 [TBL] [Abstract][Full Text] [Related]
31. Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K). Beretta S; Gritti L; Ponzoni L; Scalmani P; Mantegazza M; Sala M; Verpelli C; Sala C Mol Autism; 2022 Jan; 13(1):1. PubMed ID: 34980259 [TBL] [Abstract][Full Text] [Related]
32. PQBP1 promotes translational elongation and regulates hippocampal mGluR-LTD by suppressing eEF2 phosphorylation. Shen Y; Zhang ZC; Cheng S; Liu A; Zuo J; Xia S; Liu X; Liu W; Jia Z; Xie W; Han J Mol Cell; 2021 Apr; 81(7):1425-1438.e10. PubMed ID: 33662272 [TBL] [Abstract][Full Text] [Related]
33. Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases. Beretta S; Gritti L; Verpelli C; Sala C Neuroscience; 2020 Oct; 445():42-49. PubMed ID: 32088293 [TBL] [Abstract][Full Text] [Related]
34. Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress. Kruiswijk F; Yuniati L; Magliozzi R; Low TY; Lim R; Bolder R; Mohammed S; Proud CG; Heck AJ; Pagano M; Guardavaccaro D Sci Signal; 2012 Jun; 5(227):ra40. PubMed ID: 22669845 [TBL] [Abstract][Full Text] [Related]
35. cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner. Smith EM; Proud CG EMBO J; 2008 Apr; 27(7):1005-16. PubMed ID: 18337751 [TBL] [Abstract][Full Text] [Related]
36. Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling. Wang X; Regufe da Mota S; Liu R; Moore CE; Xie J; Lanucara F; Agarwala U; Pyr Dit Ruys S; Vertommen D; Rider MH; Eyers CE; Proud CG Mol Cell Biol; 2014 Nov; 34(22):4088-103. PubMed ID: 25182533 [TBL] [Abstract][Full Text] [Related]
37. Myostatin inhibits eEF2K-eEF2 by regulating AMPK to suppress protein synthesis. Deng Z; Luo P; Lai W; Song T; Peng J; Wei HK Biochem Biophys Res Commun; 2017 Dec; 494(1-2):278-284. PubMed ID: 29024627 [TBL] [Abstract][Full Text] [Related]
38. Functionally distinct roles for eEF2K in the control of ribosome availability and p-body abundance. Smith PR; Loerch S; Kunder N; Stanowick AD; Lou TF; Campbell ZT Nat Commun; 2021 Nov; 12(1):6789. PubMed ID: 34815424 [TBL] [Abstract][Full Text] [Related]
39. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. Chen Z; Gopalakrishnan SM; Bui MH; Soni NB; Warrior U; Johnson EF; Donnelly JB; Glaser KB J Biol Chem; 2011 Dec; 286(51):43951-43958. PubMed ID: 22020937 [TBL] [Abstract][Full Text] [Related]
40. Impaired associative taste learning and abnormal brain activation in kinase-defective eEF2K mice. Gildish I; Manor D; David O; Sharma V; Williams D; Agarwala U; Wang X; Kenney JW; Proud CG; Rosenblum K Learn Mem; 2012 Feb; 19(3):116-25. PubMed ID: 22366775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]